Overview
Mark Anderson is an Endocrinologist in San Francisco, California. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Pyle Disease. His top areas of expertise are Autoimmune Polyglandular Syndrome Type 2, Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), Pyle Disease, and Type 1 Diabetes (T1D).
His clinical research consists of co-authoring 246 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Pyle Disease.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
505 Parnassus Ave, San Francisco, CA 94143
2330 Post St, San Francisco, CA 94115
Additional Areas of Focus
Dr. Anderson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Michael German is an Endocrinologist in San Francisco, California. Dr. German is rated as an Experienced provider by MediFind in the treatment of Pyle Disease. His top areas of expertise are Type 1 Diabetes (T1D), Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, and Pyle Disease.
University Of California San Francisco
Zoe Quandt is an Endocrinologist in San Francisco, California. Dr. Quandt is rated as an Advanced provider by MediFind in the treatment of Pyle Disease. Her top areas of expertise are Addison's Disease, Secondary Adrenal Insufficiency, Pituitary Apoplexy, and Empty Sella Syndrome.
Mickie Cheng is an Endocrinologist in San Francisco, California. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of Pyle Disease. Her top areas of expertise are Type 1 Diabetes (T1D), Postmenopausal Osteoporosis, Osteoporosis, and Autoimmune Polyglandular Syndrome Type 2.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
- Autoimmune Polyglandular Syndrome Type 2Dr. Anderson isDistinguished. Learn about Autoimmune Polyglandular Syndrome Type 2.
- Pyle DiseaseDr. Anderson isDistinguished. Learn about Pyle Disease.
- Type 1 Diabetes (T1D)Dr. Anderson isDistinguished. Learn about Type 1 Diabetes (T1D).
- Advanced
- IPEX SyndromeDr. Anderson isAdvanced. Learn about IPEX Syndrome.
- Experienced
- Addison's DiseaseDr. Anderson isExperienced. Learn about Addison's Disease.
- Congenital Generalized LipodystrophyDr. Anderson isExperienced. Learn about Congenital Generalized Lipodystrophy.
- Diabetic KetoacidosisDr. Anderson isExperienced. Learn about Diabetic Ketoacidosis.
- FolliculitisDr. Anderson isExperienced. Learn about Folliculitis.
- GigantismDr. Anderson isExperienced. Learn about Gigantism.
- HypoparathyroidismDr. Anderson isExperienced. Learn about Hypoparathyroidism.